Adults Need Vaccines Too !
Protection for
a Healthier Tomorrow
Essential vaccines tailored for older adults to safeguard health and boost immunity.
As adults age, their immune systems decline due to a process called immunosenescence, reducing their ability to respond to infections. This makes older adults more susceptible to diseases like influenza, pneumococcal pneumonia, tetanus, diphtheria, or shingles.
The weakened immune response is marked by lower production of new immune cells, decreased function of existing cells, and slower reaction times, which can turn routine infections into life-threatening conditions.
Influenza Vaccine
Influenza is often underestimated but can be life-threatening for older adults. The WHO recommends annual flu vaccines for vulnerable groups, including seniors, to reduce severe complications like pneumonia, hospitalization, and death. With weakened immunity and chronic conditions, older adults benefit greatly from yearly vaccination.
In India, the primary flu season occurs during the monsoon, with a secondary peak in winter, unlike the fall season in Western countries. This difference makes April to June the ideal vaccination period. The WHO recommends using the Southern Hemisphere vaccine formulation, tailored yearly to match strains in tropical regions. Timely vaccination with the appropriate strains is crucial to reduce severe flu risks for older adults and other vulnerable groups.
In India, pneumococcal vaccination is recommended for older adults, especially those aged 60 and above, to protect against serious infections like pneumonia, meningitis, and bloodstream infections caused by Streptococcus pneumoniae.
There are two types of pneumococcal vaccines recommended for older adults:
- Pneumococcal Conjugate Vaccine (PCV 13): The PCV13 vaccine protects against 13 types of pneumococcal bacteria. It is typically administered first in older adults who have never received a pneumococcal vaccine before.
- Pneumococcal Polysaccharide Vaccine: The PPSV23 vaccine covers a broader range of 23 pneumococcal strains and is usually administered at least 1 year after the PCV13 vaccine.
Pneumococcal Vaccines
Pneumococcal Vaccination Protocol in India:
For adults aged 60 and above who have never received a pneumococcal vaccine:
- First, a single dose of PCV13 is given.
- After 1 year, a dose of PPSV23 is administered.
- A 5-yearly booster dose of PPSV23 is also recommended for individuals who remain at high risk due to chronic conditions or other health factors.
For adults with chronic conditions (like diabetes, heart disease, or chronic lung disease), or those with weakened immune systems, pneumococcal vaccination is also recommended even before 60 years of age.
Shingles Vaccine
The shingles vaccine is essential for preventing herpes zoster, a painful condition caused by the reactivation of the varicella-zoster virus, which remains dormant in the body after an individual has had chickenpox. As adults age, the risk of this viral reactivation increases, making those aged 50 and older particularly vulnerable. Complications may include herpes zoster ophthalmicus, which can threaten vision, and post-herpetic neuralgia, characterized by persistent pain long after the rash has healed.
The Recombinant Zoster Vaccine (RZV) is highly effective, with an efficacy rate of over 90% in preventing shingles and its associated complications, significantly reducing the risk of severe symptoms, which can include intense pain and rash. RZV’s high efficacy holds strong even in older adults, offering lasting protection.
The vaccine requires two doses at an interval of 2-6 months and is recommended for older adults to lessen the severity of symptoms and enhance their overall quality of life.
Tdap vaccine can prevent tetanus, diphtheria, and pertussis.
Diphtheria and pertussis spread from person to person. Tetanus enters the body through cuts or wounds.
Tetanus causes painful muscle stiffening and can lead to severe health issues, including difficulty opening the mouth, swallowing, breathing, and even death.
Diphtheria (d) can lead to difficulty breathing, heart failure, paralysis, or death.
Pertussis (ap), also known as “whooping cough,” can cause uncontrollable, violent coughing that makes it hard to breathe, eat, or drink, an occasional rib fracture from severe coughing.
Tdap Vaccine
The Tdap vaccine is recommended for older adults to protect against tetanus, diphtheria, and pertussis (whooping cough), diseases that can pose serious risks, especially with advancing age.
In India, the National Immunisation Schedule advises a single dose of the Tdap vaccine for adults who have not previously received it to establish protection. For continued immunity, a Td (tetanus and diphtheria) booster is recommended every 10 years.
This vaccination is especially important for older adults who may be in close contact with infants and young children, as it helps prevent the transmission of pertussis to these more vulnerable populations.
Hepatitis A Vaccine
The Hepatitis A vaccine protects against the hepatitis A virus (HAV), which causes liver inflammation and can lead to symptoms like fatigue, nausea, and jaundice.
Although often mild, hepatitis A can be severe, especially in older adults or those with underlying liver conditions.
The vaccine is typically administered in two doses over six months and is recommended for travelers to areas where hepatitis A is common, individuals with chronic liver disease, and those at higher risk of infection.
Vaccination provides long-lasting immunity, significantly reducing the risk of hepatitis A infection and helping to prevent outbreaks in communities and high-risk settings.
The Hepatitis B vaccine protects against the hepatitis B virus (HBV), which attacks the liver and can lead to chronic liver disease, cirrhosis, or liver cancer.
HBV spreads through contact with infected blood or bodily fluids, making vaccination crucial for healthcare workers, people with liver disease, and those at higher risk of exposure.
Hepatitis B Vaccine
The vaccine is usually administered in a series of three doses at 0, 1, and 6 months providing long-term immunity and effectively reducing the risk of HBV infection. Vaccinating against hepatitis B not only protects individuals but also helps prevent the spread of HBV in communities, improving overall public health.
HPV Vaccine
The HPV vaccine protects against the human papillomavirus (HPV), a common virus linked to various cancers, including cervical, anal, and throat cancers, as well as genital warts.
It is most effective when given before exposure to the virus, typically recommended for preteens aged 11 to 12 but can be administered as early as age 9. The vaccine is also beneficial for older teens and young adults up to age 26. By preventing infection with high-risk HPV strains, the vaccine significantly reduces the likelihood of HPV-related cancers. Widespread HPV vaccination contributes to better public health by lowering cancer rates and promoting long-term immunity.